North America Blood Testing Market was worth $19.45 billion in 2018 and estimated to be growing at a CAGR of 2.32%, to reach $21.82 billion by 2023. Rising government initiatives and increase in the number of surgical procedures in North America are the factors propelling the demand for blood tests in this region.
Demand for blood is endlessly increasing with patients undergoing complex surgeries that involve blood transfusions. For the support of patients, countries are growing their healthcare treatment so that maximum number of people can benefit out of required treatment.
Increasing concerns about spread of infectious diseases through donated blood has augmented the demand for blood and blood products. With the boost in geriatric population and incidence of diseases, there is a raise in the blood testing in the developed regions such as North America. The cost of blood handling equipment is a key challenge faced by the blood testing market.
The North America blood testing market is segmented on the basis of type into Complete Blood Count, Blood Chemistry Tests, Blood Enzymes Tests and Blood Clotting Tests. Complete Blood Count segmented is further divided into Red Blood Cells, White Blood Cells, Haemoglobin, Hematocrit and Platelets. Blood Chemistry Tests are bifurcated among Test for Electrolytes, Blood Glucose, Calcium and Test for Kidney Function. Blood Enzymes Tests are sub segmented into Troponin and Creatine Kinase. Blood Clotting Tests Segment is segregated among Prothrombin time and Activated Partial Thromboplastin time and Blood Coagulation. On the basis of diseases the market is divided into Anaemia, Infection, Leukaemia, Hypokalemia, Kidney Disorders, Heart Attack and Coronary Heart Disease. Based on Methods, market is bifurcated among Manual Blood Culture Testing and Automated Blood Culture Testing. Automated Blood Culture Testing division is further sub segmented into Automated Blood Culture System and Blood Culture Instruments.
Based on geography the North America market is analysed under various countries namely, USA and Canada. USA is leading the region’s market in terms of revenue followed by Canada.
Major players in this market are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Complete Blood Count
5.1.1.1 Red Blood Cells
5.1.1.2 White Blood Cells
5.1.1.3 Haemoglobin
5.1.1.4 Hematocrit
5.1.1.5 Platelets
5.1.2 Blood Chemistry Tests
5.1.2.1 Test for Electrolytes
5.1.2.2 Blood Glucose
5.1.2.3 Calcium
5.1.2.4 Test for Kidney Function
5.1.3 Blood Enzyme Tests
5.1.3.1 Troponin
5.1.3.2 Creatine Kinase
5.1.4 Blood Clotting Tests
5.1.4.1 Prothrombin time
5.1.4.2 Activated Partial Thromboplastin time
5.1.4.3 Blood Coagulation
5.2 By Diseases
5.2.1 Anaemia
5.2.2 Infection
5.2.3 Leukaemia
5.2.4 Hypokalemia
5.2.5 Kidney Disorders
5.2.6 Heart Attack
5.2.7 Coronary Heart Disease
5.3 By Methods
5.3.1 Manual Blood Culture Testing
5.3.2 Automated Blood Culture Testing
5.3.2.1 Automated Blood Culture System
5.3.2.2 Blood Culture Instruments
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Bio-Rad Laboratories Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Siemens Healthcare
8.3 Grifols
8.4 Nanosphere Inc.
8.5 BioMérieux
8.6 Dickinson and Company
8.7 Ortho Clinical Diagnostics Inc.
8.8 Roche Diagnostics
8.9 Alere Inc.
8.10 Bruker Corporation
8.11 Abbott Laboratories
8.12 Thermo Fisher Scientific Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
